Core Viewpoint - Sealed Air Corporation has entered into a definitive agreement with CD&R for an acquisition valued at $10.3 billion, with a purchase price of $42.15 per share, and the transaction is expected to close in mid-2026 [1][4]. Group 1: Transaction Details - The "go-shop" period for Sealed Air's acquisition expired on December 16, 2025, during which the company solicited alternative acquisition proposals from 29 parties, resulting in six parties entering confidentiality agreements [2]. - Following the expiration of the "go-shop" period, Sealed Air is now subject to "no-shop" provisions, limiting its ability to negotiate with third parties [3]. - The transaction is contingent upon stockholder approval, regulatory clearances, and other customary closing conditions [4]. Group 2: Company Overview - Sealed Air Corporation is a global leader in packaging solutions, generating $5.4 billion in sales in 2024 and employing approximately 16,400 people across 117 countries [6]. - The company specializes in food and protective packaging solutions, with well-known brands including CRYOVAC®, SEALED AIR®, LIQUIBOX®, AUTOBAG®, and BUBBLE WRAP® [6].

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores. ...

Core Points - Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties related to the sale of Sealed Air Corporation to funds affiliated with CD&R for $42.15 per share in cash [1] - Exact Sciences Corporation is being sold to Abbott for $105.00 per common share in cash, and Mersana Therapeutics, Inc. is being sold to Day One Biopharmaceuticals, Inc. [2] - The firm may seek increased consideration for shareholders, additional disclosures, or other relief on behalf of shareholders, operating on a contingent fee basis [3] Company Investigations - Sealed Air Corporation's sale price is $42.15 per share in cash [1] - Exact Sciences Corporation's sale price is $105.00 per common share in cash [2] - Mersana Therapeutics, Inc. is involved in a sale to Day One Biopharmaceuticals, Inc. [2] Legal Rights and Options - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options free of charge [4] - The firm represents investors globally who have experienced securities fraud and corporate misconduct [4]

Core Insights - Sealed Air Corporation (SEE) has entered into a definitive agreement with CD&R for an all-cash acquisition valued at $10.3 billion, aligning with its transformation strategy [1][6] - Shareholders will receive $42.15 per share, reflecting a 41% premium over the stock price as of August 14, 2025, and a 24% premium above the 90-day volume-weighted average price (VWAP) [2][6] - The acquisition has been approved by Sealed Air's Board of Directors and is expected to close by mid-2026, with the company going private and remaining headquartered in Charlotte, NC [3][6] Financial Performance - In Q3 2025, Sealed Air reported adjusted earnings per share of 87 cents, exceeding the Zacks Consensus Estimate of 68 cents, marking a 10.1% year-over-year increase [4] - Total sales for the quarter were $1.35 billion, surpassing the Zacks Consensus Estimate of $1.31 billion, with a year-over-year increase of 0.5% despite a 1% decline in volumes [4] Stock Performance - Over the past year, Sealed Air's shares have increased by 22.8%, contrasting with a 31.5% decline in the broader industry [5]

Group 1: Repare Therapeutics Inc. - Repare Therapeutics Inc. is being investigated for potential violations of federal securities laws related to its sale to XenoTherapeutics, Inc. [1] - Upon closing of the proposed transaction, each Repare shareholder is estimated to receive a cash payment of $1.82 per share, along with a non-transferable contingent value right for additional cash payments under certain conditions [1]. Group 2: Sealed Air Corporation - Sealed Air Corporation is involved in a sale to funds affiliated with CD&R for $42.15 in cash per share [2]. Group 3: Legal Representation and Shareholder Rights - Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures, and other relief on behalf of shareholders [3]. - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options at no charge [4].

Core Viewpoint - Class Action Attorney Juan Monteverde is investigating Sealed Air Corp. regarding its proposed sale to Clayton, Dubilier & Rice, LLC, where shareholders would receive $42.10 per share in cash, raising questions about the fairness of the deal [1]. Group 1: Company Overview - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has recovered millions for shareholders [1]. - The firm is located in the Empire State Building, New York City, and specializes in class action securities litigation [2]. Group 2: Transaction Details - Sealed Air shareholders are set to receive $42.10 per share in cash as part of the proposed transaction with Clayton, Dubilier & Rice, LLC [1].

Core Insights - Sealed Air has agreed to a $6.2 billion buyout by private equity firm CD&R, with shares sliding about 3% following the announcement [1][6] - The all-cash deal offers investors $42.15 per share, which is 2.6% lower than the closing price on the previous Friday but 16% higher than the price before acquisition talks began [2][6] - The transaction, with an enterprise value of $10.3 billion, is expected to close in the middle of next year [5] Company Overview - Sealed Air, based in Charlotte, N.C., is known for manufacturing bubble wrap and other packaging solutions [1] - The company's chair, Henry Keizer, expressed confidence that the transaction delivers significant value for stockholders and the company [4] Industry Context - Private equity firms are increasingly active in the packaging and industrials sector, driven by rising costs and uneven demand [3] - The trend of taking companies private allows investors to restructure manufacturers without the pressures of public market scrutiny [3]

Core Viewpoint - Johnson Fistel, PLLP has initiated an investigation into potential breaches of fiduciary duties by the board members of Sealed Air Corporation regarding the proposed acquisition by CD&R, which is perceived to undervalue the company’s shares [1][2]. Group 1: Company Overview - Sealed Air Corporation has entered into a definitive merger agreement with CD&R, where CD&R will acquire all outstanding shares of Sealed Air common stock for $42.15 per share in cash [2]. Group 2: Legal Firm Background - Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with multiple offices across the United States, representing both individual and institutional investors in securities class action lawsuits [3]. Group 3: Achievements of the Law Firm - In 2024, Johnson Fistel was ranked among the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services, having recovered approximately $90.725 million for clients in cases where it served as lead or co-lead counsel [4].

Core Insights - Sealed Air Corporation (NYSE:SEE) is a significant entity in the global packaging industry, focusing on innovative food and protective packaging solutions [1] - The company has agreed to be acquired by Clayton, Dubilier & Rice (CD&R) for $10.3 billion, offering shareholders $42.15 per share, which represents a 41% premium over the unaffected share price [2] - Current trading price of SEE is $43.28, reflecting an increase of approximately 1.84% [3][5] Financial Metrics - Sealed Air's market capitalization is approximately $6.37 billion [4] - The stock has experienced a trading volume of 5.78 million shares [4] - Over the past year, SEE's stock has fluctuated between a high of $44.27 and a low of $22.78 [3][5] Analyst Insights - Lars Kjellberg from Stifel Nicolaus has set a price target of $45 for SEE, indicating a potential upside of about 3.97% from the current trading price [1][5]

Core Viewpoint - The Ademi Firm is investigating Sealed Air for potential breaches of fiduciary duty and other legal violations related to its recent transaction with CD&R, which involves a significant cash payout to shareholders [1][3]. Transaction Details - Sealed Air shareholders will receive $42.15 in cash per share in an all-cash transaction, with an enterprise value of $10.3 billion [2]. - Insiders of Sealed Air are set to receive substantial benefits as part of the change of control arrangements [2]. Board Conduct - The transaction agreement imposes significant penalties on Sealed Air if it accepts competing bids, which may limit the board's ability to consider other offers [3]. - The investigation focuses on whether the Sealed Air board is fulfilling its fiduciary duties to all shareholders amidst these limitations [3].